Literature DB >> 34208041

OX40L-OX40 Signaling in Atopic Dermatitis.

Masutaka Furue1, Mihoko Furue2.   

Abstract

OX40 is one of the co-stimulatory molecules expressed on T cells, and it is engaged by OX40L, primarily expressed on professional antigen-presenting cells such as dendritic cells. The OX40L-OX40 axis is involved in the sustained activation and expansion of effector T and effector memory T cells, but it is not active in naïve and resting memory T cells. Ligation of OX40 by OX40L accelerates both T helper 1 (Th1) and T helper 2 (Th2) effector cell differentiation. Recent therapeutic success in clinical trials highlights the importance of the OX40L-OX40 axis as a promising target for the treatment of atopic dermatitis.

Entities:  

Keywords:  OX40; OX40L; Th1 cell; Th17 cell; Th2 cell; atopic dermatitis; dendritic cell

Year:  2021        PMID: 34208041     DOI: 10.3390/jcm10122578

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  4 in total

Review 1.  Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis.

Authors:  El-Bdaoui Haddad; Sonya L Cyr; Kazuhiko Arima; Robert A McDonald; Noah A Levit; Frank O Nestle
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-21

Review 2.  Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets.

Authors:  Junhu Tai; Munsoo Han; Tae Hoon Kim
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

3.  Special Issue "Pathogenesis, Epidemiology and Treatment of Atopic Dermatitis and Psoriasis".

Authors:  Masutaka Furue
Journal:  J Clin Med       Date:  2021-12-04       Impact factor: 4.241

Review 4.  Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical Relevance.

Authors:  Xin Ma; Yi Ru; Ying Luo; Le Kuai; Qi-Long Chen; Yun Bai; Ye-Qiang Liu; Jia Chen; Yue Luo; Jian-Kun Song; Mi Zhou; Bin Li
Journal:  Front Cell Dev Biol       Date:  2022-07-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.